Cargando…
Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
BACKGROUND AND OBJECTIVE: During atrial fibrillation ablation, heparin is required and is guided by the activated clotting time (ACT). Differences in the ACT before ablation and adequate initial heparin dosing in patients receiving non-vitamin K antagonist oral anticoagulants (NOACs) were examined....
Autores principales: | Yamaji, Hirosuke, Murakami, Takashi, Hina, Kazuyoshi, Higashiya, Shunich, Kawamura, Hiroshi, Murakami, Masaaki, Kamikawa, Shigeshi, Komtasubara, Issei, Kusachi, Shozo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021748/ https://www.ncbi.nlm.nih.gov/pubmed/27389243 http://dx.doi.org/10.1007/s40261-016-0435-6 |
Ejemplares similares
-
Activated clotting time on the day of atrial fibrillation ablation for minimally interrupted and uninterrupted direct oral anticoagulation therapy: Sequential changes, differences among direct oral anticoagulants, and ablation safety outcomes
por: Yamaji, Hirosuke, et al.
Publicado: (2019) -
Safety and Efficacy of Underdosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation
por: Yamaji, Hirosuke, et al.
Publicado: (2017) -
Adjunctive interpulmonary isthmus ablation has no added effects on atrial fibrillation recurrence
por: Higashiya, Shunichi, et al.
Publicado: (2017) -
Correlation of the peak oxygen consumption and ventilatory aerobic threshold by cardiopulmonary exercise testing with atrial fibrillation recurrences after ablation in patients with paroxysmal atrial fibrillation
por: Yamashita, Daiki, et al.
Publicado: (2020) -
Reproducibility of cardiopulmonary exercise testing between one after and 1–3 weeks after elective percutaneous coronary intervention
por: Tanaka, Ryou, et al.
Publicado: (2023)